[1]
Parmar, A., Qazi, A.A. , Stundzia, A. , Sim, H.-W., Lewin, J. , Metser, U. , O’Malley, M. and Hansen, A.R. 2021. Development of a radiomic signature for predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Canadian Urological Association Journal. 16, 3 (Oct. 2021), E113–9. DOI:https://doi.org/10.5489/cuaj.7294.